MTND2P17

Across TCGA pan-cancer cohorts, MTND2P17 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MTND2P17 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTND2P17 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND2P17 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCEC, THYM, and READ are the cancer types where MTND2P17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.261	0.703	<.001	72	view →
THYM	OS	Tertile	All	0.186	0.931	<.001	45	view →
READ	DFS	Tertile	All	0.255	0.844	.004	45	view →
ACC	OS	Tertile	II,III,IV	0.135	0.658	.010	36	view →
LUAD	OS	Tertile	III,IV	0.223	0.677	.006	36	view →
ESCA	DFS	Tertile	II,III,IV	0.853	0.283	.013	30	view →
BRCA	DFS	Tertile	II,III,IV	0.775	0.943	.012	24	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
KIRP	DFS	Tertile	All	0.251	0.623	.009	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MTND2P17–UCEC (OS)

Open the UCEC breakdown →